# ATELVIA
> **NDA022560** · New Drug Application · Sponsor: APIL · Approved 2010-10-08
## Drug
- **FDA Application Number:** NDA022560
- **Application type:** New Drug Application
- **Brand name:** ATELVIA
- **Generic name:** RISEDRONATE SODIUM
- **Active ingredients:** RISEDRONATE SODIUM
- **Dosage form:** TABLET, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** APIL
- **Manufacturer:** Allergan, Inc.
- **First approval:** 2010-10-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022560)
---
*AI Analytics · CC0 1.0*